Afferent drive of medial prefrontal cortex by hippocampus and amygdala is altered in MAM-treated rats: Evidence for interneuron dysfunction

Neuropsychopharmacology

Volumn 38, Issue 10, 2013, Pages 1871-1880

  Esmaeili, Behnaz ^a   Grace, Anthony A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

amygdale; hippocampus; NMDA; prefrontal cortex; schizophrenia

Indexed keywords

METHYLAZOXYMETHANOL ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; CONTROLLED STUDY; DRIVE; EVOKED RESPONSE; HIPPOCAMPUS; INTERNEURON; MALE; NERVE STIMULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ACTION POTENTIALS; AMYGDALA; ANIMALS; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; INTERNEURONS; MALE; METHYLAZOXYMETHANOL ACETATE; NEURAL INHIBITION; NEURAL PATHWAYS; NEUROTOXINS; PHENCYCLIDINE; PREFRONTAL CORTEX; RATS; SCHIZOPHRENIA;

EID: 84882456500     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.64     Document Type: Article

References (72)

1. Allen P, Luigjes J, Howes OD, Egerton A, Hirao K, Valli I et al (2012). Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals. Schizophr Bull 38: 1268-1276.
2. Bacon SJ, Headlam AJ, Gabbott PL, Smith AD (1996). Amygdala input to medial prefrontal cortex (mPFC) in the rat: a light and electron microscope study. Brain Res 720: 211-219.
3. Bartos M, Vida I, Frotscher M, Meyer A, Monyer H, Geiger JRP et al (2002). Fast synaptic inhibition promotes synchronized gamma oscillations in hippocampal interneuron networks. Proc Natl Acad Sci USA 99: 13222-13227.
4. Bartos M, Vida I, Jonas P (2007). Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 8: 45-56.
5. Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL et al (2007). Ketamine-induced loss of phenotype of fastspiking interneurons is mediated by NADPH-oxidase. Science 318: 1645-1647.
6. Benes FM (2010). Amygdalocortical circuitry in schizophrenia: from circuits to molecules. Neuropsychopharmacology 35: 239-257.
7. Berretta S, Lange N, Bhattacharyya S, Sebro R, Garces J, Benes FM (2004). Long-term effects of amygdala GABA receptor blockade on specific subpopulations of hippocampal interneurons. Hippocampus 14: 876-894.
8. Bitanihirwe BKY, Lim MP, Kelley JF, Kaneko T, Woo TUW (2009). Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. BMC Psychiatry 9: 71.
9. Buzsáki G, Leung LW, Vanderwolf CH (1983). Cellular bases of hippocampal EEG in the behaving rat. Brain Res 287: 139-171.
10. Carr DB, Sesack SR (1996). Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals. J Comp Neurol 369: 1-15.
11. Cohen BD, Rosenbaum G, Luby ED, Gottlieb JS (1962). Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential think. Arch Gen Psychiatry 6: 395-401.
12. Corcoran KA, Desmond TJ, Frey KA, Maren S (2005). Hippocampal inactivation disrupts the acquisition and contextual encoding of fear extinction. J Neurosci 25: 8978-8987.
13. Coyle JT (1996). The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 3: 241-253.
14. Cunningham MO, Hunt J, Middleton S, LeBeau FEN, Gillies MJ, Gillies MG et al (2006). Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness. J Neurosci 26: 2767-2776.
15. Domino EF, Luby ED (2012). Phencyclidine/schizophrenia: one view toward the past, the other to the future. Schizophr Bull 38: 914-919.
16. Feltenstein MW, See RE (2008). The neurocircuitry of addiction: an overview. Br J Pharmacol 154: 261-274.
17. Flagstad P, M-rk A, Glenth-j BY, Beek J van, Michael-Titus AT, Didriksen M (2004). Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamineinduced dopamine release in nucleus accumbens. Neuropsychopharmacology 29: 2052-2064.
18. Floresco SB, Grace AA (2003). Gating of hippocampal-evoked activity in prefrontal cortical neurons by inputs from the mediodorsal thalamus and ventral tegmental area. J Neurosci 23: 3930-3943.
19. Floresco SB, Tse MT (2007). Dopaminergic regulation of inhibitory and excitatory transmission in the basolateral amygdalaprefrontal cortical pathway. J Neurosci 27: 2045-2057.
20. Fuchs RA, Evans KA, Ledford CC, Parker MP, Case JM, Mehta RH et al (2005). The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology 30: 296-309.
21. Gabbott P, Headlam A, Busby S (2002). Morphological evidence that CA1 hippocampal afferents monosynaptically innervate PVcontaining neurons and NADPH-diaphorase reactive cells in the medial prefrontal cortex (Areas 25/32) of the rat. Brain Res 946: 314-322.
22. Gabbott PL, Dickie BG, Vaid RR, Headlam AJ, Bacon SJ (1997). Local-circuit neurones in the medial prefrontal cortex (areas 25, 32 and 24b) in the rat: morphology and quantitative distribution. J Comp Neurol 377: 465-499.
23. Gabbott PLA (2003). Radial organisation of neurons and dendrites in human cortical areas 25, 32, and 32'. Brain Res 992: 298-304.
24. Gabbott PLA, Warner TA, Busby SJ (2006). Amygdala input monosynaptically innervates parvalbumin immunoreactive local circuit neurons in rat medial prefrontal cortex. Neuroscience 139: 1039-1048.
25. Garcia R, Vouimba RM, Baudry M, Thompson RF (1999). The amygdala modulates prefrontal cortex activity relative to conditioned fear. Nature 402: 294-296.
26. Gigg J, Tan AM, Finch DM (1994). Glutamatergic hippocampal formation projections to prefrontal cortex in the rat are regulated by GABAergic inhibition and show convergence with glutamatergic projections from the limbic thalamus. Hippocampus 4: 189-198.
27. Goldberg TE, Weinberger DR (1988). Probing prefrontal function in schizophrenia with neuropsychological paradigms. Schizophr Bull 14: 179-183.
28. Goto Y, Grace AA (2006). Alterations in medial prefrontal cortical activity and plasticity in rats with disruption of cortical development. Biol Psychiatry 60: 1259-1267.
29. Gourevitch R, Rocher C, Pen G Le, Krebs M-O, Jay TM (2004). Working memory deficits in adult rats after prenatal disruption of neurogenesis. Behav Pharmacol 15: 287-292.
30. Grace AA, Moore H (1998). Regulation of information flow in the nucleus accumbens: a model for the pathophysiology of schizophrenia. In: Lenzenweger MF, Dworkin RH (eds). Origins and development of schizophrenia: advances in experimental psychopathology. American Psychological Association: Washington, DC, pp 123-157.
31. Homayoun H, Moghaddam B (2007). NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27: 11496-11500.
32. Ishikawa A, Nakamura S (2003). Convergence and interaction of hippocampal and amygdalar projections within the prefrontal cortex in the rat. J Neurosci 23: 9987-9995.
33. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308.
34. Jay TM, Glowinski J, Thierry AM (1995). Inhibition of hippocampoprefrontal cortex excitatory responses by the mesocortical DA system. Neuroreport 6: 1845-1848.
35. Ji J, Maren S (2007). Hippocampal involvement in contextual modulation of fear extinction. Hippocampus 17: 749-758.
36. Jodo E, Suzuki Y, Takeuchi S, Niwa S, Kayama Y (2003). Different effects of phencyclidine and methamphetamine on firing activity of medial prefrontal cortex neurons in freely moving rats. Brain Res 962: 226-231.
37. Laviolette SR, Lipski WJ, Grace AA (2005). A subpopulation of neurons in the medial prefrontal cortex encodes emotional learning with burst and frequency codes through a dopamine D4 receptor-dependent basolateral amygdala input. J Neurosci 25: 6066-6075.
38. Lewis DA (2012). Cortical circuit dysfunction and cognitive deficits in schizophrenia - implications for preemptive interventions. Eur J Neurosci 35: 1871-1878.
39. Lewis DA, Curley AA, Glausier JR, Volk DW (2012). Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci 35: 57-67.
40. Lewis DA, Fish KN, Arion D, Gonzalez-Burgos G (2011). Perisomatic inhibition and cortical circuit dysfunction in schizophrenia. Curr Opin Neurobiol 21: 866-872.
41. Lewis DA, Hashimoto T (2007). Deciphering the disease process of schizophrenia: the contribution of cortical GABA neurons. Int Rev Neurobiol 78: 109-131.
42. Lewis DA, Hashimoto T, Volk DW (2005). Cortical inhibitory neurons and schizophrenia. Na Rev Neurosci 6: 312-324.
43. Lewis DA, Moghaddam B (2006). Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 63: 1372-1376.
44. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RS (1992). Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 160: 179-186.
45. Lodge DJ, Behrens MM, Grace AA (2009). A loss of parvalbumincontaining interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci 29: 2344-2354.
46. Maren S (2008). Pavlovian fear conditioning as a behavioral assay for hippocampus and amygdala function: cautions and caveats. Eur J Neurosci 28: 1661-1666.
47. Maren S, Quirk GJ (2004). Neuronal signalling of fear memory. Nat Revi Neurosci 5: 844-852.
48. McDonald AJ (1991). Organization of amygdaloid projections to the prefrontal cortex and associated striatum in the rat. Neuroscience 44: 1-14.
49. Mcdonald AJ (1996). Glutamate and aspartate immunoreactive neurons of the rat basolateral amygdala: colocalization of excitatory amino acids and projections to the limbic circuit. J Comp Neurol 365: 367-379.
50. Milad MR, Quirk GJ (2002). Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420: 70-74.
51. Milad MR, Vidal-Gonzalez I, Quirk GJ (2004). Electrical stimulation of medial prefrontal cortex reduces conditioned fear in a temporally specific manner. Behav Neurosci 118: 389-394.
52. Moghaddam B, Adams BW (1998). Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281: 1349-1352.
53. Moore H, Jentsch JD, Ghajarnia M, Geyer MA, Grace AA (2006). A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol Psychiatry 60: 253-264.
54. Orsini CA, Kim JH, Knapska E, Maren S (2011). Hippocampal and prefrontal projections to the basal amygdala mediate contextual regulation of fear after extinction. J Neurosci 31: 17269-17277.
55. Paxinos G, Watson C (1986). The rat brain in stereotaxic coordinates. Academic: Sydney.
56. Penschuck S, Flagstad P, Didriksen M, Leist M, Michael-Titus AT (2006). Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia. Eur J Neurosci 23: 279-284.
57. Pérez-Jaranay JM, Vives F (1991). Electrophysiological study of the response of medial prefrontal cortex neurons to stimulation of the basolateral nucleus of the amygdala in the rat. Brain Res 564: 97-101.
58. Phillips RG, LeDoux JE (1992). Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106: 274-285.
59. Reynolds GP (1983). Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305: 527-529.
60. Rosenkranz JA, Grace AA (2002). Dopamine-mediated modulation of odour-evoked amygdala potentials during pavlovian conditioning. Nature 417: 282-287.
61. Santana N, Troyano-Rodriguez E, Mengod G, Celada P, Artigas F (2011). Activation of thalamocortical networks by the N-methyl- D-aspartate receptor antagonist phencyclidine: reversal by clozapine. Biol Psychiatry 69: 918-927.
62. Selden NR, Everitt BJ, Jarrard LE, Robbins TW (1991). Complementary roles for the amygdala and hippocampus in aversive conditioning to explicit and contextual cues. Neuroscience 42: 335-350.
63. Shinonaga Y, Takada M, Mizuno N (1994). Topographic organization of collateral projections from the basolateral amygdaloid nucleus to both the prefrontal cortex and nucleus accumbens in the rat. Neuroscience 58: 389-397.
64. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S et al (1995). A functional neuroanatomy of hallucinations in schizophrenia. Nature 378: 176-179.
65. Stefani MR, Moghaddam B (2002). Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat. Behav Brain Res 134: 267-274.
66. Suzuki Y, Jodo E, Takeuchi S, Niwa S, Kayama Y (2002). Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats. Neuroscience 114: 769-779.
67. Volk DW, Lewis DA (2002). Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol Behav 77: 501-505.
68. Whittington MA, Traub RD, Jefferys JG (1995). Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature 373: 612-615.
69. Wolf RC, Vasic N, Sambataro F, Ho?se A, Frasch K, Schmid M et al (2009). Temporally anticorrelated brain networks during working memory performance reveal aberrant prefrontal and hippocampal connectivity in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 33: 1464-1473.
70. Woo TU, Whitehead RE, Melchitzky DS, Lewis DA (1998). A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 95: 5341-5346.
71. Zhang ZJ, Reynolds GP (2002). A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res 55: 1-10.
72. Zhou Y, Shu N, Liu Y, Song M, Hao Y, Liu H et al (2008). Altered resting-state functional connectivity and anatomical connectivity of hippocampus in schizophrenia. Schizophr Res 100: 120-132..